A patient undergoing treatment for metastatic melanoma experiences some unusual symptoms. Watch this case to figure out what is going on.
This activity is intended for oncologists, dermatologists, and pathologists.
The goal of this activity is to review the treatment options and risks for immune-related adverse effects in patients being treated for metastatic melanoma.
Approximate Time to Complete: 20 minutes
Course Available Beginning: Oct. 21, 2016
Developed through a partnership between SITC and Medscape.
Upon completion of this activity, participants will be able to:
- Select the most appropriate treatment regiment for a patient with metastatic melanoma based on their tumor's BRAF status, tumor burden, medical history, prior treatments and presenting symptoms
- Identify strategies to prevent and/or mitigate treatment-related adverse effects in patients with metastatic melanoma.